Gilead Sciences, Inc.
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences DTL — Property, plant and equipment by Year
DTL — Property, plant and equipment ($M) ($M)
Gilead Sciences DTL — Property, plant and equipment: $288M in FY2025, up 4.3% from a year earlier. That is the highest of the 8 years on record here.
Latest, FY2025
288
Period ended Dec 31, 2025
Change on a year earlier
+4.3%
276 in FY2024
History
8 years
Since FY2018
Sources
7
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-24) ↗
Reported in Form 10-K Note 15.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | DTL — Property, plant and equipment ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 288 | +4.3% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 276 | +0.7% | Form 10-K (filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 274 | +17.1% | Form 10-K (filed 2025-02-28) ↗ |
| FY2022 | Dec 31, 2022 | 234 | +3.1% | Form 10-K (filed 2024-02-23) ↗ |
| FY2021 | Dec 31, 2021 | 227 | +12.4% | Form 10-K (filed 2023-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 202 | +129.5% | Form 10-K (filed 2022-02-23) ↗ |
| FY2019 | Dec 31, 2019 | 88 | +87.2% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 47 | – | Form 10-K (filed 2020-02-25) ↗ |
Cite this data
StockData. (2026). Gilead Sciences DTL — Property, plant and equipment ($M), annual FY2018–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/dtl-ppe-row
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.